RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...

Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...

The for-sale Green Hills property home to a 2023-opened CVS Pharmacy — and related to Metro’s future realignment of a key ...

CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more integrated system ...

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...

Here’s what to know about Donald Trump’s NIH funding cuts. Americans are struggling with rising costs and high anxiety around ...

CVS CEO David Joyner's comments come as lawmakers on both sides of the aisle and President Donald Trump have signaled ...

CVS appears uniquely positioned to improve health outcomes, and we appreciate management's focus on better leveraging its assets through digital and other means to bring a more consumer-centric ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. The ...

(Reuters) - CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that ...

| With budget reconciliation right around the corner, different slices of the healthcare industry have made their views clear on issues like physician pay, ACA subsidies, telehealth flexibilities, ...